Patrick Baeuerle

Insider Reports History

Entity
Individual
Location
Woldpromenade 18 C, Gauting, Germany
Signature
/s/ Jacquelyn Sumer, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Patrick Baeuerle:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Cullinan Oncology, Inc. Chief Scientific Officer Common Stock 341K $4.25M $12.46 Feb 17, 2023 Indirect
Cullinan Oncology, Inc. Chief Scientific Officer Common Stock 76K $947K $12.46 Feb 17, 2023 Direct
Cullinan Oncology, Inc. Chief Scientific Officer Stock Option (Right to Buy) 77K Feb 17, 2023 Direct

Insider Reports Filed by Patrick Baeuerle

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CGEM Cullinan Oncology, Inc. Feb 17, 2023 2 $0 4 Feb 21, 2023 Chief Scientific Officer
CGEM Cullinan Oncology, Inc. Feb 11, 2022 2 $0 4 Feb 15, 2022 Acting Chief Scientific Officer, Biologics
CGEM Cullinan Oncology, Inc. Sep 8, 2021 3 -$266K 4 Sep 9, 2021 Acting Chief Scientific Officer, Biologics
CGEM Cullinan Oncology, Inc. Aug 10, 2021 3 -$250K 4 Aug 26, 2021 Acting Chief Scientific Officer, Biologics